Shunsuke Maehara

4PUBLICATIONS
2CO-AUTHORS
Clinical pharmacology and therapeuticsBiologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 01, 2020
Combination of the phosphodiesterase 10A inhibitor, MR1916 with risperidone shows additive antipsychotic-like effects without affecting cognitive enhancement and cataleptic effects in rats.

Keita Arakawa, Shunsuke Maehara

|Apr 28, 2020
Pharmacological characterization of a novel potent, selective, and orally active orexin 2 receptor antagonist, SDM-878.

Shunsuke Maehara, Natsuko Yuge, Chika Higashi

|Mar 08, 2020
Ameliorative effects of a phosphodiesterase 10A inhibitor, MR1916 on L-DOPA-induced dyskinesia in parkinsonian rats.

Keita Arakawa, Natsuko Yuge, Shunsuke Maehara

|Feb 27, 2020
Pharmacological characterization of a novel, potent, selective, and orally active fatty acid amide hydrolase inhibitor, PKM-833 [(R)-N-(pyridazin-3-yl)-4-(7-(trifluoromethyl)chroman-4-yl)piperazine-1-carboxamide] in rats: Potential for the treatment of inflammatory pain.

Toshiya Endo, Takashi Takeuchi, Shunsuke Maehara

Pageof 1

Frequent Collaborators

1 joint publications

Toshiya Endo

1 joint publications

Keita Arakawa